Skip to Main Content

Paper Details

Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.
Sci Adv
2
2022
Author NameAffiliation
Anne Y WarrenUniversity of Cambridge, Addenbrooke's Hospital
Charlie E MassieUniversity of Cambridge, Hutchison-MRC Research Centre
Charlie E MassieEarly Cancer Institute
  • 1 - 3

Datasets

Release 1.2